Zeey, Pain Relieving Gel-Patch, Lidocaine 4%, N 5, N 15, N 18

Manufacturer
Shanghai Chuangshi Medical Technology (Group) Co., Ltd.
Effective date
2026-05-14
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
full-release
Hydrated at
2026-06-01 01:57:36

Label at a glance#

ProductPain Relieving Gel-Patch
Active ingredientLIDOCAINE
Label structure16 sections

Indications and uses

For temporary relief of pain

Dosage and administration

Adult and Children 12 years of age and over : Clean and dry affected area Remove film from patch and apply to the skin (see illustration) Apply 1 patch at a time to affected area, not more than 3 to 4 times daily Remove patch from the skin after at most 8-hour application Children under 12 years of age : Consult a doctor

Storage and handling

Avoid storing product in direct sunlight Protect product from excessive moisture

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4% ...... Purpose: Topical Anesthetic

Purpose

OTC - PURPOSE SECTION

Topical Anesthetic

Uses

INDICATIONS & USAGE SECTION

For temporary relief of pain

Warnings

WARNINGS SECTION

For external use only

Ask a doctor if:

OTC - ASK DOCTOR SECTION

  • localized skin reactions occur, such as rash, itching, redness, irritation, pain, swelling and blistering
  • Conditions worsen
  • Symptoms persists for more than 7 days
  • Symptoms clear up and occur again within a few days

When using this product

OTC - WHEN USING SECTION

  • Use only as directed
  • Avoid contact with the eyes, mucous membranes or rashed
  • Do not bandage tightly

Do not use

OTC - DO NOT USE SECTION

  • More than 1 patch at a time
  • On wounds or damaged skin
  • With a heating pad
  • If you are allergic to any ingredients of this product

Stop use if:

OTC - STOP USE SECTION

  • localized skin reactions occur, such as rash, itching, redness, irritation, pain, swelling and blistering
  • Conditions worsen
  • Symptoms persists for more than 7 days
  • Symptoms clear up and occur again within a few days

Pregnancy or breast feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breastfeeding, ask a health professional before use

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Adult and Children 12 years of age and over:

  • Clean and dry affected area
  • Remove film from patch and apply to the skin (see illustration)
  • Apply 1 patch at a time to affected area, not more than 3 to 4 times daily
  • Remove patch from the skin after at most 8-hour application

Children under 12 years of age: Consult a doctor

Dosage forms & strengths

DOSAGE FORMS & STRENGTHS SECTION

This is a strip, patch dosage form.

The active ingredient strength is 4% w/w.

One patch one time, no more than 8 hours one time.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Glycerin, Sodium Polyacrylate, Dihydroxyaluminum Aminoacetate, Disodium Ethylenediaminetetraacetic Acid, Kaolin, Titanium Dioxide, Polysorbate 80, Propylene Glycol, Tartaric Acid, Polyacrylic Acid, Polyvinylpyrrolidone K90, Methylparaben, Propylparaben, Water

Questions or Comments?

OTC - QUESTIONS SECTION

1 646-223-0128 · Lu.FDAmanage@gmail.com

Other information

STORAGE AND HANDLING SECTION

  • Avoid storing product in direct sunlight
  • Protect product from excessive moisture

Package label. Principal display panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

0101050515151818

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1737778lidocaine 4 % Medicated PatchPSN6
1737778lidocaine 0.04 MG/MG Medicated PatchSCD6
1737778lidocaine 4 % Medicated PatchSY6

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LIDOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-136924239705649GTIN-13: 6924239705649
EAN-13: 6924239705649
GTIN storage (14 digits): 06924239705649
157-01.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73557-157-01Pain Relieving Gel-Patch12 g in 1 PATCHPATCH126
73557-157-05Pain Relieving Gel-Patch5 in 1 BOXPATCH56
73557-157-15Pain Relieving Gel-Patch15 in 1 BOXPATCH156
73557-157-18Pain Relieving Gel-Patch18 in 1 BOXPATCH186

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73557-15773557-157-01, 73557-157-05, 73557-157-15, 73557-157-18

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Pain Relieving Gel-PatchLIDOCAINEShanghai Chuangshi Medical Technology (Group) Co., Ltd.f1045448-ae78-eba6-e053-2a95a90a67932026-05-14WarningsExact identifier
ndc (package): 73557-157-15
ndc (package): 73557-157-01
ndc (package): 73557-157-05
ndc (package): 73557-157-18
ndc (product): 73557-157
ndc11 (package): 73557015705
ndc11 (package): 73557015715
ndc11 (package): 73557015701
ndc11 (package): 73557015718
spl id: 51d37ae8-bd17-1094-e063-6294a90ae368
spl set id: f1045448-ae78-eba6-e053-2a95a90a6793

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.